• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Jan 3, 2018
Preclinical News

CYLD expression could slow progression of NASH

Read More
BioCentury | May 31, 2017
Distillery Therapeutics

Hepatic; endocrine / metabolic

Read More
BioCentury | May 18, 2017
Targets & Mechanisms

Degrading NASH

How TMBIM1 could calm inflammation in NASH
Read More
BioCentury | May 10, 2017
Clinical News

China researchers identify potential NASH target

Read More
Items per page:
1 - 4 of 4